Inhibrx Biosciences, Inc. (INBX) Form 10-Q Quarterly Reports
Inhibrx Biosciences, Inc. (INBX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INBX
CIK: 2007919
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerBrian Taggart
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-14 | FORM 4 | 0001366074-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-25 | FORM 4 | 0001366074-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-28 | 8-K | 0002007919-26-000050 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-23 | FORM 4 | 0001366268-26-000011 | View SEC Doc Filr Page |
| 4/A | 2026-09-18 | 2026-06-03 | FORM 4/A | 0001240801-26-000006 | View SEC Doc Filr Page |
| 4/A | 2026-09-18 | 2026-06-03 | FORM 4/A | 0001612627-26-000007 | View SEC Doc Filr Page |
| 4/A | 2026-09-18 | 2026-06-03 | FORM 4/A | 0001202094-26-000009 | View SEC Doc Filr Page |
| 4/A | 2026-09-18 | 2026-06-03 | FORM 4/A | 0001366268-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-16 | FORM 4 | 0001366268-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | FORM 4 | 0001202094-26-000006 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001959173-26-006980 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001959173-26-006953 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001959173-26-006886 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0001202094-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001959173-26-006844 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001959173-26-006805 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | FORM 4 | 0001366268-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | FORM 4 | 0001240801-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | FORM 4 | 0001366074-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0002007919-26-000047 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352639 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193805-26-001095 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000905148-26-003736 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0002007919-26-000044 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0002007919-26-000042 | View SEC Doc Filr Page |